Cargando…
Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
Dopamine agonists are one of the main stay of treatment option for Parkinson disease (PD). Side effects that develop from their use are generally categorized into behavioral and non-behavioral. Behavioral side effects include: impulse control behavior disorder (ICD), psychosis and cognitive impairme...
Autores principales: | Mohammad, Mohammad Edrees, Vizcarra, Joaquin A., Garcia, Xiomara, Patel, Shnehal, Margolius, Adam, Yu, Xin Xin, Fernandez, Hubert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299972/ https://www.ncbi.nlm.nih.gov/pubmed/34316669 http://dx.doi.org/10.1016/j.prdoa.2021.100091 |
Ejemplares similares
-
Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review
por: Garcia, Xiomara, et al.
Publicado: (2022) -
Prevalence of hypersexual behavior in Parkinson’s disease patients: Not restricted to males and dopamine agonist use
por: Cooper, Christine A, et al.
Publicado: (2009) -
The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008) -
Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology
por: Borovac, Josip Anđelo
Publicado: (2016) -
Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)